E.L. Rojas-Calderón

Author

E.L. Rojas-Calderón

Instituto Nacional de Investigaciones Nucleares

Also Known As

E. Rojas-Calderón, E.L. Rojas-Calderon, E.L. Rojas-Calderón, Eva L. Rojas-Calderón, Eva Rojas-Calderón

Publications

137

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Investigaciones Nucleares Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Universidad Autónoma del Estado de México

About

E.L. Rojas-Calderón is an author at Instituto Nacional de Investigaciones Nucleares specializing in radiation oncology, engineering, and nuclear medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	2	2	42
2	Medicine	2	2	42
3	Pharmacology	1	1	23
4	Brachytherapy	1	1	19
5	Dosimetry	1	1	19

E.L. Rojas-Calderón

Publications

115

Citations

H-Index

Page 1

	Year	Citations
Lys<SUP>3</SUP>-Bombesin Conjugated to<SUP>99m</SUP>Tc-Labelled Gold Nanoparticles for <I>In Vivo</I> Gastrin Releasing Peptide-Receptor Imaging Andrei N. Mendoza-Sánchez, Guillermina Ferro‐Flores, Blanca Ocampo‐García, Journal of Biomedical Nanotechnology	2010	45
99mTc-N2S2-Tat (49-57)-bombesin internalized in nuclei of prostate and breast cancer cells Clara Santos‐Cuevas, Guillermina Ferro‐Flores, E.L. Rojas-Calderón, Nuclear Medicine Communications	2011	28
Preparation and preclinical evaluation of 66Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical V. López‐Rodríguez, R. E. Gaspar-Carcamo, Martha Pedraza-López, Nuclear Medicine and Biology Medicinal ChemistryEngineeringPreclinical EvaluationRadionuclide TherapyMedicine	2014	23
Assessment of the radiation absorbed dose produced by 177Lu-iPSMA, 225Ac-iPSMA and 223RaCl2 to prostate cancer cell nuclei in a bone microenvironment model Erika Azorín‐Vega, E.L. Rojas-Calderón, Guillermina Ferro‐Flores, Applied Radiation and Isotopes Bone Microenvironment ModelEngineeringMedicineBrachytherapyRadiation Exposure	2019	19

Page 1